162 related articles for article (PubMed ID: 31348270)
21. Preoperative PI-RADS Version 2 scores helps improve accuracy of clinical nomograms for predicting pelvic lymph node metastasis at radical prostatectomy.
Huang C; Song G; Wang H; Lin Z; Wang H; Ji G; Zhang S; Guo Y; Li J; Bao Z; Hong P; Du Y; Li P; He Q; He S; Gong Y; Wang X; Zhou L
Prostate Cancer Prostatic Dis; 2020 Mar; 23(1):116-126. PubMed ID: 31383954
[TBL] [Abstract][Full Text] [Related]
22. Development and external validation of a nomogram to predict lymph node invasion after robot assisted radical prostatectomy.
Tosco L; Devos G; De Coster G; Roumeguère T; Everaerts W; Quackels T; Dekuyper P; Van Cleynenbreugel B; Van Damme N; Van Eycken E; Ameye F; Joniau S;
Urol Oncol; 2020 Feb; 38(2):37.e11-37.e20. PubMed ID: 31727561
[TBL] [Abstract][Full Text] [Related]
23. Validation of nomograms predicting lymph node involvement in patients with prostate cancer undergoing extended pelvic lymph node dissection.
Hinev AI; Anakievski D; Kolev NH; Hadjiev VI
Urol Int; 2014; 92(3):300-5. PubMed ID: 24480972
[TBL] [Abstract][Full Text] [Related]
24. Predicting the risk of lymph node invasion during radical prostatectomy using the European Association of Urology guideline nomogram: a validation study.
Schmitges J; Karakiewicz PI; Sun M; Abdollah F; Budäus L; Isbarn H; Bianchi M; Trinh QD; Schlomm T; Chun FK; Graefen M; Steuber T
Eur J Surg Oncol; 2012 Jul; 38(7):624-9. PubMed ID: 22531769
[TBL] [Abstract][Full Text] [Related]
25. Predictors of Lymph Node Invasion in Patients with Clinically Localized Prostate Cancer Who Undergo Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: The Role of Obesity.
Tafuri A; Rizzetto R; Amigoni N; Sebben M; Shakir A; Gozzo A; Odorizzi K; Gallina S; Bianchi A; Ornaghi P; Brunelli M; Migliorini F; Cerruto MA; Artibani W; Siracusano S; Antonelli A; Porcaro AB
Urol Int; 2021; 105(5-6):362-369. PubMed ID: 33059351
[TBL] [Abstract][Full Text] [Related]
26. A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals.
Bandini M; Marchioni M; Preisser F; Nazzani S; Tian Z; Fossati N; Gandaglia G; Shariat SF; Montorsi F; Saad F; Briganti A; Tilki D; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):449-456. PubMed ID: 29249688
[TBL] [Abstract][Full Text] [Related]
27. Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion.
Oderda M; Diamand R; Albisinni S; Calleris G; Carbone A; Falcone M; Fiard G; Gandaglia G; Marquis A; Marra G; Parola C; Pastore A; Peltier A; Ploussard G; Roumeguère T; Sanchez-Salas R; Simone G; Smelzo S; Witt JH; Gontero P
BJU Int; 2021 Mar; 127(3):318-325. PubMed ID: 32869940
[TBL] [Abstract][Full Text] [Related]
28. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.
Leyh-Bannurah SR; Budäus L; Zaffuto E; Pompe RS; Bandini M; Briganti A; Montorsi F; Schiffmann J; Shariat SF; Fisch M; Chun F; Huland H; Graefen M; Karakiewicz PI
Urol Oncol; 2018 Feb; 36(2):81.e17-81.e24. PubMed ID: 29248430
[TBL] [Abstract][Full Text] [Related]
29. Prostate-specific antigen associates with extensive lymph node invasion in high-risk prostate cancer.
Porcaro AB; Corsi P; Inverardi D; Sebben M; Tafuri A; Processali T; Mattevi D; De Marchi D; Pirozzi M; Cerruto MA; Amigoni N; Rizzetto R; Brunelli M; Siracusano S; Artibani W
Tumori; 2018 Aug; 104(4):307-311. PubMed ID: 29714659
[TBL] [Abstract][Full Text] [Related]
30. Predicting lymph node invasion in patients treated with robot-assisted radical prostatectomy.
Abdollah F; Klett DE; Sammon JD; Dalela D; Sood A; Hsu L; Diaz M; Gupta N; Peabody JO; Trinh QD; Menon M
Can J Urol; 2016 Feb; 23(1):8141-50. PubMed ID: 26892054
[TBL] [Abstract][Full Text] [Related]
31. Head to head comparison of nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended pelvic lymph node dissection.
Walz J; Bladou F; Rousseau B; Laroche J; Salem N; Gravis G; Briganti A; Chun FK; Karakiewicz PI; Fournier G
Urology; 2012 Mar; 79(3):546-51. PubMed ID: 22386393
[TBL] [Abstract][Full Text] [Related]
32. Assessing the risk of lymph node invasion in patients with intermediate risk prostate cancer treated with extended pelvic lymph node dissection. A novel prediction tool.
Briganti A; Capitanio U; Abdollah F; Gallina A; Suardi N; Bianchi M; Tutolo M; Salonia A; Freschi M; Rigatti P; Montorsi F
Prostate; 2012 Apr; 72(5):499-506. PubMed ID: 22468270
[TBL] [Abstract][Full Text] [Related]
33. Development of a novel nomogram to identify the candidate to extended pelvic lymph node dissection in patients who underwent mpMRI and target biopsy only.
Fiori C; Checcucci E; Stura I; Amparore D; De Cillis S; Piana A; Granato S; Volpi G; Sica M; Piramide F; Verri P; Manfredi M; De Luca S; Autorino R; Migliaretti G; Porpiglia F
Prostate Cancer Prostatic Dis; 2023 Jun; 26(2):388-394. PubMed ID: 35750851
[TBL] [Abstract][Full Text] [Related]
34. Updated Nomogram Incorporating Percentage of Positive Cores to Predict Probability of Lymph Node Invasion in Prostate Cancer Patients Undergoing Sentinel Lymph Node Dissection.
Winter A; Kneib T; Wasylow C; Reinhardt L; Henke RP; Engels S; Gerullis H; Wawroschek F
J Cancer; 2017; 8(14):2692-2698. PubMed ID: 28928857
[No Abstract] [Full Text] [Related]
35. Validation and head-to-head comparison of three nomograms predicting probability of lymph node invasion of prostate cancer in patients undergoing extended and/or sentinel lymph node dissection.
Grivas N; Wit E; Tillier C; van Muilekom E; Pos F; Winter A; van der Poel H
Eur J Nucl Med Mol Imaging; 2017 Dec; 44(13):2213-2226. PubMed ID: 28780722
[TBL] [Abstract][Full Text] [Related]
36. Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era.
Kim KH; Lim SK; Kim HY; Han WK; Choi YD; Chung BH; Hong SJ; Rha KH
BJU Int; 2014 Apr; 113(4):598-604. PubMed ID: 24006951
[TBL] [Abstract][Full Text] [Related]
37. External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging.
Soeterik TFW; Hueting TA; Israel B; van Melick HHE; Dijksman LM; Stomps S; Biesma DH; Koffijberg H; Sedelaar M; Witjes JA; van Basten JA
BJU Int; 2021 Aug; 128(2):236-243. PubMed ID: 33630398
[TBL] [Abstract][Full Text] [Related]
38. Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.
Briganti A; Chun FK; Salonia A; Zanni G; Scattoni V; Valiquette L; Rigatti P; Montorsi F; Karakiewicz PI
Eur Urol; 2006 Jun; 49(6):1019-26; discussion 1026-7. PubMed ID: 16530933
[TBL] [Abstract][Full Text] [Related]
39. Identifying candidates for super-extended staging pelvic lymph node dissection among patients with high-risk prostate cancer.
Gandaglia G; Zaffuto E; Fossati N; Bandini M; Suardi N; Mazzone E; Dell'Oglio P; Stabile A; Freschi M; Montorsi F; Briganti A
BJU Int; 2018 Mar; 121(3):421-427. PubMed ID: 29063734
[TBL] [Abstract][Full Text] [Related]
40. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
